Skip to content

A study to test how well different and multiple doses of BI 3034701 are tolerated in people living with overweight or obesity

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-526090-42-00
Enrollment
35
Registered
2026-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity, overweight

Interventions

None listed

Sponsors

Boehringer Ingelheim International GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Aug 20, 2026